Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies.
Vaccines (Basel). 2021 Mar 3;9(3):214. doi: 10.3390/vaccines9030214.
Vaccines (Basel). 2021.
PMID: 33802467
Free PMC article.